Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC
Status:
Completed
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of aprepitant combined with ondansetron and dexamethasone
to prevent nausea and vomiting induced by Intensity-modulated Radiotherapy (IMRT)
cisplatin-chemotherapy regimen in locally advanced squamous cell carcinoma of head and neck